Published 6 April 2009, doi:10.1136/bmj.b1432
Cite this as: BMJ 2009;338:b1432

News

Court hears how drug giant Merck tried to "neutralise" and "discredit" doctors critical of Vioxx

Ray Moynihan

1 Byron Bay, Australia

The first 150 words of the full text of this article appear below.

The drug company Merck drew up a list of influential doctors and researchers it wanted to "neutralise" and "discredit," as part of its marketing of the arthritis drug Vioxx (rofecoxib), according to evidence heard by an Australian court this week.

Details of the plans to "neutralise" doctors surfaced during a class action against Merck on behalf of hundreds of Australians who had heart attacks or strokes after taking the drug, which was withdrawn in 2004 after concerns about safety.

Julian Burnside QC, acting for the plaintiffs, read extracts from company emails sent between Merck staff that discussed a "list of ‘problem’ physicians that we must, at a minimum, neutralise."

The list dates from 1999 when questions were first raised about the safety of rofecoxib, and there was intense competition within the market for cyclo-oxygenase-2 selective non-steroidal anti-inflammatory drugs. The list included more than 30 US hospital and university based doctors, . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Merck disguised "marketing publication" as medical journal to help promote Vioxx, court hears
Ray Moynihan
BMJ 2009 338: b1714. [Extract] [Full Text]

Access jobs at BMJ Careers
Whats new online at Student BMJ